Market Access & Pricing
There are many barriers to accessing markets in the CEE: the high price of high-value medicines and low GDP per capita are just some of them. Medis knows how to operate successfully in these markets.
Our market access team has achieved more than 100 positive reimbursement decisions for high-value specialty and orphan drugs in the region.
Our success lies in our expertise and ability to collaborate with sales, marketing, and medical departments. We discover unmet market needs and then deliver the best products to meet them profitably.
We take a systematic, step-by-step approach to achieve positive reimbursement results:
- Building a comprehensive local access strategy
- Effectively communicating compelling value to stakeholders
- Aligning the global value dossier with country-specific submission documents
- Negotiating better pricing and reimbursement terms
- Ensuring accelerated approval and maintaining effective pricing and reimbursement solutions
As the market access environment continues to evolve and change, constant learning is required to develop new techniques and capabilities. Market access success cannot be the domain of the pricing and reimbursement team alone. Only a fully integrated organisation can implement the processes, techniques and strategies required to deliver the right messages to the right stakeholders at the right time.Alja Plevnik KapunMarket Access and Medical Director Medis Therapeutics